Evidence map›Paper›PMID 19553343›Full record

ArticleRNA (New York, N.Y.)2009

Fluorescently labeled ribosomes as a tool for analyzing antibiotic binding.

Beatriz Llano-Sotelo, Robyn P Hickerson, Laura Lancaster, Harry F Noller, Alexander S Mankin

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Overview on Strategies and Assays for Antibiotic Discovery.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  2. Article
  3. Article
  4. Antimicrobial Resistance inMicrobiology spectrum · 2018
    Review
  5. Article
  6. Techniques for Screening Translation Inhibitors.Antibiotics (Basel, Switzerland) · 2016
    Review
  7. Article
  8. Article
  9. Article
  10. Allosteric control of the ribosome by small-molecule antibiotics.Nature structural & molecular biology · 2012
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Beatriz Llano-SoteloCenter for Pharmaceutical Biotechnology, University of Illinois, Chicago, Illinois 60607, USA.
Robyn P Hickerson
Laura Lancaster
Harry F Noller
Alexander S Mankin

Funding

Novel Therapeutics for Bacillus anthracisU19AI056575 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI JOHNSON, MICHAEL E. · 2003 to 2007
$15.5M
NIAID NIH HHS U19 AI056575NIAID NIH HHS U19 AI56575
6 · The paper itself

Abstract

Measuring the binding of antibiotics and other small-molecular-weight ligands to the 2.5 MDa ribosome often presents formidable challenges. Here, we describe a general method for studying binding of ligands to ribosomes that carry a site-specific fluorescent label covalently attached to one of the ribosomal proteins. As a proof of principle, an environment-sensitive fluorescent group was placed at several specific sites within the ribosomal protein S12. Small ribosomal subunits were reconstituted from native 16S rRNA, individually purified small subunit proteins, and fluorescently labeled S12. The fluorescence characteristics of the reconstituted subunits were affected by several antibiotics, including streptomycin and neomycin, which bind in the vicinity of protein S12. The equilibrium dissociation constants of the drugs obtained using a conventional fluorometer were in good agreement with those observed using previously published methods and with measurements based on the use of radiolabeled streptomycin. The newly developed method is rapid and sensitive, and can be used for determining thermodynamic and kinetic binding characteristics of antibiotics and other small ribosomal ligands. The method can readily be adapted for use in high-throughput screening assays.

Indexed as

Anti-Bacterial AgentsBinding SitesEscherichia coli ProteinsFluorescent DyesKineticsLigandsModels, MolecularNeomycinRibosomal ProteinsRibosomesRNA, BacterialRNA, Ribosomal, 16SSensitivity and SpecificitySpectrometry, FluorescenceStreptomycinThermodynamicsAnti-Bacterial AgentsEscherichia coli ProteinsFluorescent DyesLigandsNeomycinRibosomal Proteinsribosomal protein S12RNA, BacterialRNA, Ribosomal, 16SStreptomycin

Identifiers

PMID19553343
PMCPMC2714759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.